MorphoSys AG

XTRA:MOR Rapporto sulle azioni

Cap. di mercato: €2.5b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

MorphoSys Gestione

Gestione criteri di controllo 1/4

We currently do not have sufficient information about the CEO.

Informazioni chiave

Arkadius Pichota

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEOless than a year
Proprietà del CEOn/a
Durata media del managementless than a year
Durata media del Consiglio di amministrazione6.5yrs

Aggiornamenti recenti sulla gestione

Recent updates

Would MorphoSys (ETR:MOR) Be Better Off With Less Debt?

Apr 30
Would MorphoSys (ETR:MOR) Be Better Off With Less Debt?

MorphoSys AG's (ETR:MOR) 93% Share Price Surge Not Quite Adding Up

Dec 25
MorphoSys AG's (ETR:MOR) 93% Share Price Surge Not Quite Adding Up

Is MorphoSys (ETR:MOR) Weighed On By Its Debt Load?

Aug 24
Is MorphoSys (ETR:MOR) Weighed On By Its Debt Load?

Does MorphoSys (ETR:MOR) Have A Healthy Balance Sheet?

May 16
Does MorphoSys (ETR:MOR) Have A Healthy Balance Sheet?

MorphoSys AG (ETR:MOR) Held Back By Insufficient Growth Even After Shares Climb 36%

Apr 17
MorphoSys AG (ETR:MOR) Held Back By Insufficient Growth Even After Shares Climb 36%

MorphoSys AG (ETR:MOR) Analysts Are More Bearish Than They Used To Be

Nov 26
MorphoSys AG (ETR:MOR) Analysts Are More Bearish Than They Used To Be

AMMINISTRATORE DELEGATO

Arkadius Pichota

less than a year

Mandato

Mr. Arkadius Pichota, Ph D., MBA., is Chief Executive Officer of MorphoSys AG from June 2024. Mr. Pichota served as President, General Manager and Chairman of the Board of the Novartis subsidiary Navigate...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Charlotte Lohmann
Chief Legal and Human Resources Officer & Member of Management Board4.6yrs€1.10m0.0036%
€ 90.9k
Arkadius Pichota
Chief Executive Officerless than a yearNessun datoNessun dato
Lukas Gilgen
Chief Financial Officerless than a yearNessun datoNessun dato
Tim Demuth
Chief Research & Development Officer1.8yrsNessun datoNessun dato
Klaus De Wall
Head of Accounting & Taxno dataNessun datoNessun dato
Margit Urban
Head of Discovery Alliances & Technologiesno dataNessun datoNessun dato
Julia Neugebauer
Head of Investor Relationsno dataNessun datoNessun dato
Barbara Krebs-Pohl
Chief Business Officerno dataNessun datoNessun dato
Günter Wellnhofer
Head of Technical Operationsno dataNessun datoNessun dato
Harald Watzka
Head of Alliance Managementno dataNessun datoNessun dato
Yen Ching Chua
Head of Clinical Operationsno dataNessun datoNessun dato
Kathrin Tissot
Head of Business Teamno dataNessun datoNessun dato

1.0yrs

Durata media

Gestione esperta: MOR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.

Membri del Consiglio di amministrazione

NomePosizioneMandatoCompensazioneProprietà
Bruce Cheson
Member of Scientific Advisory Board7.9yrsNessun datoNessun dato
Gunther Adolf
Member of Scientific Advisory Board7.9yrsNessun datoNessun dato
Sergio Quezada
Member of Scientific Advisory Board7.9yrsNessun datoNessun dato
Raymond Sweet
Member of Scientific Advisory Board7.9yrsNessun datoNessun dato
Sharon Curran
Independent Member of Supervisory Board5.2yrs€92.60kNessun dato
Heinrich V. Moisa
Chairman of the Supervisory Boardless than a yearNessun datoNessun dato
Silke Mainka
Member of the Supervisory Boardless than a yearNessun datoNessun dato
Romain Lege
Deputy Chairman of the Supervisory Boardless than a yearNessun datoNessun dato

6.5yrs

Durata media

51yo

Età media

Consiglio di amministrazione esperto: MOR's board of directors are considered experienced (6.5 years average tenure).